Viral startup claims AGI achieved in private preview
Single-source blog post drives social cascade; no benchmarks, no third-party access, no peer review.
HYPEXIO tracks the next decade — AI, biotech, fusion, quantum — and scores every claim with Reality, Hype, and Impact meters. So you see what is real before everyone else does.
Otoferlin mutation reversed in pediatric cohort with measurable speech-recognition gains at six months.
Three independent monitoring teams confirmed the longest stable run yet — pulling grid-scale fusion measurably closer to engineering reality.
Eighteen-month silence ends after engineers re-route signal through a long-dormant transmitter.
Single-source blog post drives social cascade; no benchmarks, no third-party access, no peer review.
Three independent monitoring teams confirmed the longest stable run yet — pulling grid-scale fusion measurably closer to engineering reality.
Eighteen-month silence ends after engineers re-route signal through a long-dormant transmitter.
A 7B parameter checkpoint posts competitive scores on a contested benchmark — peers question the evaluation harness.
Otoferlin mutation reversed in pediatric cohort with measurable speech-recognition gains at six months.
Updated meltwater dynamics push the median estimate higher; uncertainty interval narrows.
Single-source blog post drives social cascade; no benchmarks, no third-party access, no peer review.
Single-source blog post drives social cascade; no benchmarks, no third-party access, no peer review.
Low reality score, high hype resonance. Where the community amplifies what is not yet there.